Clinical Research Details

Descriptive Information
Excellent intubating conditions with remifentanil-propofol and either low-dose rocuronium or succinylcholine

Marie Maroun-Aouad


Clinical Research - Clinical Trials (phase 0, 1,2 3 & 4)  

  • Sahar Siddik Sayyid
  • Samar Taha Bohsaly
  • Ghassan Kanazi
  • Mohammad Khatib
  • Anis Baraka
Conditions and Keywords
intubating conditions
tracheal intubation;succinylcholine; rocuronium
Study Design
Eligibility and IRB
Min: 18
Max: 60
In Progress

male and female patients who were ASA physical status I to II, aged 18–60 years, and scheduled for elective orthopedic, gynecologic, and otorhinolaryngological ambulatory surgery

a history of gastroesophageal reflux, hypertension, asthma, drug or alcohol abuse, cardiovascular disease, body mass index >30 kg · m−2, neuromuscular disease or medication influencing neuromuscular transmission, and anticipated difficult intubation. Also excluded were patients with a contraindication to the use of succinylcholine, such as predisposition to malignant hyperthermia, decreased pseudocholinesterase activity or known genetic variation, and conditions causing susceptibility to succinylcholine-induced hyperkalemia (for example burn or denervation injury).